hormone (SIADH) is not so frequent but it is a representative entity of hyponatremia. Although the clinical features were established by Bartter and Schwartz more than 30 years ago (1), a prototype of their diagnostic criteria has been applied so far.
Hyponatremia is not a rare condition, especially in elderly persons. Nearly 1 to 5% of hospital patients showed hyponatremia, defined as a serum sodium level of less than 1 30 mEq// (2, 3), therefore, the appropriate differential diagnosis is essential. Hyponatremia is generally divided into two different pathophysiological states, hypervolemic and hypovolemic hyponatremia. SIADHis usually classified as normovolemic hyponatremia according to standard clinical assessment of extracellular fluid (ECF) volume. However, strictly speaking, a mild but apparent increase in ECFvolume is present which then induces dilutional hyponatremia. In clinical practice, the differentiation of these two states is important because the treatments are quite varied. Generally, water restriction is the first therapeutic choice in hypervolemic hyponatremia including SIADH,on the other hand, water deprivation aggravates the symptoms of patients with hypovolemic hyponatremia. The concept of SIADH is very familiar to physicians, thus the syndrome is readily suspected when patients with hyponatremia are encountered. There are manyconditions which resemble SIADH. For instance, cerebral salt wasting syndrome (CSWS) is often seen as hyponatremia after neurosurgery (4) . SIADH also occurs due to brain tumor or cerebrovascular accident. Both conditions show hyponatremia, urinary sodium loss and no signs of edema or thyroidal and adrenal insufficiency. However,the plasma volumeis contracted in the case ofCSWS, suggesting that water restriction as a treatment for hyponatremia should be contraindication. Hypovolemia in CSWSper se is a potent stimulating factor for antidiuretic hormone, vasopressin, secretion in even the hypo-osmolar state and it is also well known that patients with SIADHshow a detectable level of plasma vasopressin. Accordingly, the plasma vasopressin concentration does not have a positive role in the differential diagnosis of these hyponatremic states. Then, what is an effective and practical tool for differentiation of hyponatremia? Unfortunately, we do not have a simple efficient method for the evaluation ofECF or plasma volume, however, the hypervolemic state usually indicates that the plasma renin concentration or serum uric acid is low or relatively low in contrast with hypovolemic hyponatremia.
The etiology of SIADHis markedly varied, including diseases in the central nervous system or pulmonary region which maycause a disturbance in the control system of vasopressin secretion. Other mechanismsto manifest SIADHare vasopressin producing tumors or some kinds of medications. Small cell lung cancer is the most possible candidate as an ectopic vasopressin production. Vasopressin is autonomously produced from cancer cells even in the extremely low plasma osmolality and no suppression occurs until cancer resection or chemo-or irradiation-therapy for the tumor. Approximately 40%of small cell lung cancer cases showedinappropriate secretion of vasopressin and 14%of the patients indicated abnormalities in serum sodium or urine osmolality (5) . Many patients with hyponatremia do not present any clinical symptoms, especially mild (>125 mEq//) or chronic occasion. However, we must not exclude the possibility that some serious disorders may be latent or not in even asymptomatic hyponatremia. Hyponatremia sometimes appears as the first sign of malignant or severe diseases (6) .
See also p 950.
It is simple but fundamental to measure serum sodium at regular intervals especially in hospital patients, because hyponatremia-induced symptoms are rather infrequent and obscure. The apparent symptomsusually occur by rapid lowering of serum sodium or chronic hyponatremia of less than 1 20-125 mEq//.
Finally, the treatment of hyponatremia is also complicated. Acute correction of chronic hyponatremiasometimescauses an iatrogenic complication knownas myelinolysis or central pontine myelinolysis (7) . Wemust keep in mind that the correction of chronic hyponatremia needs careful consideration and the correction rate should be kept at less than 0.5 mEq///h to prevent myelinolysis.
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